Consumer Advisory Committee (CAC)
The Consumer Advisory Committee (CAC) provides PHARMAC with input from a patient or health consumer perspective. It was established in 2002 following the requirements of the New Zealand Public Health and Disability Act 2000 and provides advice to PHARMAC on a broad range of PHARMAC's activities, including around medicines funding issues. It is not, however, involved in the assessment of pharmaceutical funding applications.
The Committee meets at least twice a year, and is guided by its Terms of Reference (10 pages, 26 KB). Minutes of meetings are available here.
For more information about the Consumer Advisory Committee, read Listening to Consumers - Role of the Consumer Advisory Committee (2 pages, 90 KB)
CAC Terms of Reference Review
PHARMAC is currently consulting on a final draft version of the revised Terms of Reference for the Consumer Advisory Committee. To read more about this or to make a submission, click here.
Page updated on 05 Mar 2010
Linked documents
Consumer Advisory Committee Terms of Reference (10 pages, 26 KB)
CAC is a committee representing the interests of health consumers. The primary purpose of CAC is to provide the Board with input from a consumer or patient point of view (see section 50(1)(b) of the Act).
Listening to Consumers - role of the Consumer Advisory Committee (2 pages, 90 KB)
PHARMAC Information sheet Listening to consumers - Role of the Consumer Advisory Committee The Consumer Advisory Committee (CAC) helps PHARMAC better understand consumer and patient perspectives. CAC Consumer Advisory Committee Considering Consumer perspectives Our work directly affects the lives of…
